Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Endocrine-Related Cancer|November 25, 2010
Increased uptake of [¹²³I]meta-iodobenzylguanidine, [¹⁸F]fluorodopamine, and [³H]norepinephrine in mouse pheochromocytoma cells and tumors after treatment with the histone deacetylase inhibitorsLucia Martiniova, Shiromi M Perera, Frederieke M Brouwers, et al.
Clinical & Experimental Metastasis|January 27, 2009
Characterization of an animal model of aggressive metastatic pheochromocytoma linked to a specific gene signatureLucia Martiniova, Edwin W Lai, Abdel G Elkahloun, et al.
Neoplasia (New York, N.Y.)|September 24, 2016
Hypoxia-Inducible Factor 2α Mutation-Related Paragangliomas Classify as Discrete Pseudohypoxic SubclusterStephanie M J Fliedner, Uma Shankavaram, Geena Marzouca, et al.
Developmental Cell|May 10, 2025
Single-cell MultiOmics and spatial transcriptomics demonstrate neuroblastoma developmental plasticityYunyun Xu, Daohua Lou, Ping Chen, et al.
Endocrine-Related Cancer|April 7, 2020
A xenograft and cell line model of SDH-deficient pheochromocytoma derived from Sdhb+/- ratsJames F Powers, Brent Cochran, James D Baleja, et al.
Human Pathology|May 15, 2020
Data set for the reporting of pheochromocytoma and paraganglioma: explanations and recommendations of the guidelines from the International Collaboration on Cancer ReportingLester D R Thompson, Anthony J Gill, Sylvia L Asa, et al.
Nature Communications|July 12, 2013
Landscape of the mitochondrial Hsp90 metabolome in tumoursYoung Chan Chae, Alessia Angelin, Sofia Lisanti, et al.
Nature Communications|October 21, 2022
Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironmentMagnus Zethoven, Luciano Martelotto, Andrew Pattison, et al.
Plos One|August 4, 2012
Warburg effect's manifestation in aggressive pheochromocytomas and paragangliomas: insights from a mouse cell model applied to human tumor tissueStephanie M J Fliedner, Nina Kaludercic, Xiao-Sheng Jiang, et al.
The Journal of Clinical Endocrinology and Metabolism|July 17, 2026
Identifying TMEM127-deficient pheochromocytomas/paragangliomas via RET overexpression by immunohistochemistryCynthia M Estrada-Zuniga, Rui Liang, Bethany Landry, et al.
Pageof 10